Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Polyneuropathies 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Myeloma 1Mucositis 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Hematologic Neoplasms 1Glioma 1Frailty 1Fanconi Anemia 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Thalidomide 1Surveys and Questionnaires 1Quercetin 1Melphalan 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyneuropathies × Quercetin × Clear all
NCT02989129 2018-04-18

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn

Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡